10/27/2021Boehringer Ingelheim Submits Chinese NDA for First-in-class Spesolimab...

10/27/2021Fosun to Take on Pfizer's Prevnar with Acquisition of Antejin Biotech

10/27/2021Jemincare Group Accuses China Bohai Bank of Misusing Its CNY 2.8B Depo...

10/26/2021PhIIC's China Generic Drug Bluebook 2021: Up 3.9% in 2019 but Down 16....

10/26/2021Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818

10/26/2021I-Mab Enters Strategic Partnership with Sinopharm for Launch of its I...

10/26/2021WHO Clears Chinese HPV Vaccine in Global Battle against Cervical Cance...

10/26/2021SciNeuro and Mabylon to Co-develop Novel Therapeutics for Neurological...

10/26/2021Merck unveils first innovation collaboration site open to startups

10/26/2021How China Turned the Tables on Biopharma's Global Dealmaking: Endpoint

10/26/2021Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818

10/25/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (51...

10/25/2021111, Inc. and Chugai Pharma Enter Strategic Partnership With to Acce...

10/25/2021CANbridge Enters Global Licensing Pact with Scriptr Global to Develop...

10/25/2021Novartis's NDA for Ribociclib Accepted in China

10/25/2021IQVIA Unveils Comprehensive Analysis of Chinese Retail Pharmacy Market

10/22/2021Antengene to Join Hands with LegoChem Biosciences for Research of New...

10/22/2021NeoCura and MDimune Settle CDVs-mediated mRNA Collaboration

10/22/2021I-Mab Opens New R&D Lab in San Diego

10/22/2021China's MOFCOM Pledges Foreign Investment Expansion as It Plans to Ste...

10/22/2021Recent Executive Moves

10/22/2021SCMP: U.S. Warns American Firms to Protect Five Key Technologies

10/22/2021Reuters: EU Plans Stricter Drugs Supply Rules to Avoid Reliance on 'Au...

10/21/2021NMPA Issues the List of Reference Formulations for GQCE Studies (46th ...

10/21/2021NMPA Issues the List of Reference Formulations for GQCE Studies (47th ...

10/21/2021Luoxin Enters Licensing Deal With Austria-Based Marinomed Biotech for ...

10/21/2021Ligand and CR Double-Crane Enter Deal to Develop an Oral COVID-19 Ther...

10/20/2021CStone Received Chinese IND Acceptance of lorlatinib for ROS1-posit...

10/20/2021OliX, Pharmaron Agree to Advance Non-clinical Toxicology Testing for ...

10/20/2021LianBio to Raise up to $345M in Planned IPO at Valuation of $1.8B

Page:195/805 Total number of articles:24134: [First][<<] [193] [194] [195] [196] [197] [>>] [End]